Responding strategically

Our strategy is designed to respond to the current and expected future operating environments of the global healthcare industry, the needs and expectations of our key stakeholders, the risks and opportunities we face as a Group , as well as the resultant material matters that potentially could impact our value creation.

Accelerate the transition from a South African focused acute care group to a market-leading, international, diversified healthcare organisation by providing a diversified product and service offering, with a growing share of revenue and earnings from non-acute sources

Evolve the Group's delivery model with a dual focus on moving to an integrated healthcare model in southern Africa and being a leading diagnostic imaging provider internationally

Focus on clinical excellence and building an analytically-led, technologically-enabled Group, across all territories and businesses

STRATEGIC FOCUS AREAS	WHAT THIS MEANS	RELATED MATERIAL MATTERS
Growth Continue to grow our southern Africa business while establishing a sizeable international business, and diversify our sources of revenue	The Group seeks to be a market-leading, international, diversified healthcare organisation. This is achieved by effectively partnering with healthcare professionals to operate our acute hospital and complementary services business. Life Healthcare aims to achieve our growth objectives through a number of key initiatives, including: Expanding our complementary services footprint in South Africa Building an imaging business in South Africa, leveraging Alliance Medical's expertise, scale in procurement, best practice clinical protocols, and operational efficiencies Delivering an outpatient care model in South Africa which offers convenient, affordable and quality care through the use of cutting-edge technology and outstanding clinical employees Focus on lean operations, clinical excellence and integration for value Focusing on driving commercial sales of Neuraceq and progress to reimbursement, as well as to develop pipeline products through Life Molecular Imaging	Portfolio performance Government relationships
Efficiency Deliver cost-effective care through efficient, optimal utilisation of processes, information, technology, research, innovation and other resources	We are focused on providing high-quality care while effectively managing all costs, including cost of sales, labour and overheads. This allows the Group to maintain high levels of clinical and operational efficiency while optimally allocating resources. Relationships with our employees, healthcare funders, procurement partners and doctors are included as efficiency-enabling opportunities.	Cost of care Healthcare funders
Quality Deliver market-leading quality care	Strict adherence to protocols and processes, reporting, analysis and action for quality metrics are essential in delivering world-class healthcare to our patients. The Group aims to maintain and improve its quality performance through rigorous quality reporting and benchmarking. This includes clinical outcomes, patient satisfaction and stakeholder health and safety.	Quality of care standards Healthcare funders Labour relations and employee retention
Sustainability Effectively engage with our stakeholders to ensure our long-term sustainability	Social, environmental and financial stability, underpinned by effective stakeholder engagement, support the sustainability of our operations, both locally and internationally. The Group recognises the importance of our licences to operate in various territories and the stakeholders in each who directly influence our success. Life Healthcare remains focused on its sustainability goals.	Cost of care Specialised skills shortage Government relationships Increasing regulations Labour relations and employee retention Healthcare funders

For more information refer to how we performed against our strategy.